EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer’s Disease

A F M Towheedur Rahman iD, Sarojini Bulbule iD, Jawad Bin Belayet, Anna Benko iD, Carl Gunnar Gottschalk iD, David N Frick, Leggy A Arnold iD, M Mahmun Hossain, Avik Roy

Cells · 2024

DOI: 10.3390/cells13231964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von A F M Towheedur Rahman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, 2000 E Kenwood Blvd, Milwaukee, WI 53211, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Hippocampus, Neuronal Plasticity, Neurons. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Simmaron Research Inc., NIH R21 grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhancement of neuronal plasticity by small-molecule therapeutics protects cognitive skills and also ameliorates progressive neurodegenerative pathologies like Alzheimer’s disease (AD) and dementia. One such compound, a novel histone deacetylase 2 (HDAC2) inhibitor named JRM-28, was shown here to enhance dendritic strength, augment spine density, and upregulate post-synaptic neurotransmission in hippocampal neurons. The molecular basis for this effect correlates with JRM-28-induced upregulation of the transcription of cAMP response element-binding protein(CREB), induction of its transcriptional activity, and subsequent stimulation of expressions of CREB-dependent plasticity-associated genes, such as those encoding N-methyl-D-aspartate (NMDA) receptor subunit NR2A and the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor subunit GluR1. Specifically, JRM-28 stimulated the NMDA- and AMPA-receptor-sensitive ionotropic calcium influx in hippocampal neurons. Interestingly, JRM-28 did not induce NMDA- and AMPA-sensitive calcium influx in hippocampal neurons once the expression of CREB was knocked down by creb siRNA, suggesting the critical role of CREB in JRM-28-mediated upregulation of synaptic plasticity. Finally, JRM-28 upregulated CREB mRNA, CREB-dependent plasticity-associated markers, and ionotropic calcium influx in iPSC-derived AD human neurons, indicating its therapeutic implications in the amelioration of AD pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHippocampusNeuronal PlasticityNeuronsCyclic AMP Response Element-Binding ProteinHistone Deacetylase 2Up-RegulationAnimalsHistone Deacetylase InhibitorsHumansRatsReceptors, AMPAReceptors, N-Methyl-D-Aspartate

Stichwörter der Autor:innen

AMPA-sensitive glutamate receptor 1HDAC inhibitorHistone deacetylase 2NMDA receptor subunit 2AbenzenecAMP responsive element binding protein 2dichloromethaneimmunoblotimmunofluorescenceiodinelithium diisopropylamidemeta-chloroperoxybenzoic acidmethanolsodium acetatetetrahydrofuran

Substanzen

Cyclic AMP Response Element-Binding ProteinHistone Deacetylase 2Histone Deacetylase InhibitorsReceptors, AMPAReceptors, N-Methyl-D-Aspartate

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, 2000 E Kenwood Blvd, Milwaukee, WI 53211, USA..
  • Simmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.
  • Milwaukee Institute for Drug Discovery, 2000 E Kenwood Blvd, Milwaukee, WI 53211, USA.
  • Simmaron Research and Development Laboratory, University of Wisconsin-Milwaukee, Chemistry Building, 2000 E Kenwood Blvd, Suite # 320, Milwaukee, WI 53211, USA.

ORCID-Profile: A F M Towheedur Rahman, Sarojini Bulbule, Anna Benko, Carl Gunnar Gottschalk, Leggy A Arnold

Förderung

  • NINDS NIH HHS
  • Simmaron Research Inc.
  • NIH R21 grant
  • Ramsay Award 2023
  • Foundation Hesse Sibylla, Quebec, QC, Canada
  • Therapeutic Acceleration Program (TAP) grant to MMH by the Medical College of Wisconsin, WI

Zitieren

APA

Rahman, A. F. M. T., Bulbule, S., Belayet, J. B., Benko, A., Gottschalk, C. G., Frick, D. N., Arnold, L. A., Hossain, M. M., & Roy, A. (2024). JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer’s Disease. Cells. https://doi.org/10.3390/cells13231964

Vancouver

Rahman AFMT, Bulbule S, Belayet JB, Benko A, Gottschalk CG, Frick DN, et al. JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer’s Disease. Cells. 2024. doi:10.3390/cells13231964

BibTeX
@article{Rahman2024,
  author = {Rahman, A F M Towheedur and Bulbule, Sarojini and Belayet, Jawad Bin and Benko, Anna and Gottschalk, Carl Gunnar and Frick, David N and Arnold, Leggy A and Hossain, M Mahmun and Roy, Avik},
  title = {JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer’s Disease},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13231964}
}
Kostenlos starten →